APG Asset Management N.V. Has $61.11 Million Stake in CVS Health Co. (NYSE:CVS)

APG Asset Management N.V. lifted its position in shares of CVS Health Co. (NYSE:CVS) by 0.9% in the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 1,108,877 shares of the pharmacy operator’s stock after acquiring an additional 10,096 shares during the period. APG Asset Management N.V.’s holdings in CVS Health were worth $61,106,000 as of its most recent filing with the Securities and Exchange Commission.

Several other large investors have also made changes to their positions in CVS. Wedmont Private Capital increased its stake in shares of CVS Health by 0.8% in the 1st quarter. Wedmont Private Capital now owns 19,225 shares of the pharmacy operator’s stock valued at $1,410,000 after purchasing an additional 146 shares during the last quarter. Moody National Bank Trust Division lifted its holdings in shares of CVS Health by 0.7% in the first quarter. Moody National Bank Trust Division now owns 22,268 shares of the pharmacy operator’s stock worth $1,776,000 after acquiring an additional 150 shares during the last quarter. Landmark Financial Advisors LLC boosted its stake in shares of CVS Health by 3.8% in the 4th quarter. Landmark Financial Advisors LLC now owns 4,166 shares of the pharmacy operator’s stock valued at $329,000 after purchasing an additional 153 shares in the last quarter. Garland Capital Management Inc. grew its holdings in shares of CVS Health by 0.3% during the 2nd quarter. Garland Capital Management Inc. now owns 60,810 shares of the pharmacy operator’s stock valued at $3,591,000 after purchasing an additional 160 shares during the last quarter. Finally, Silverlake Wealth Management LLC increased its position in CVS Health by 1.6% during the 1st quarter. Silverlake Wealth Management LLC now owns 11,203 shares of the pharmacy operator’s stock worth $894,000 after purchasing an additional 173 shares in the last quarter. Institutional investors and hedge funds own 80.66% of the company’s stock.

Analysts Set New Price Targets

A number of analysts have weighed in on CVS shares. Barclays decreased their target price on shares of CVS Health from $65.00 to $63.00 and set an “equal weight” rating on the stock in a research note on Thursday, August 8th. Wells Fargo & Company upped their target price on CVS Health from $60.00 to $61.00 and gave the stock an “equal weight” rating in a report on Monday, August 12th. Royal Bank of Canada restated an “outperform” rating and set a $68.00 price target on shares of CVS Health in a report on Wednesday, September 4th. Baird R W upgraded shares of CVS Health to a “hold” rating in a report on Thursday, May 30th. Finally, Cantor Fitzgerald reissued a “neutral” rating and set a $62.00 target price on shares of CVS Health in a report on Monday, September 16th. Eleven equities research analysts have rated the stock with a hold rating and eleven have assigned a buy rating to the company. According to MarketBeat, the company has an average rating of “Moderate Buy” and a consensus price target of $72.10.

CVS Health Stock Up 0.6 %

Shares of CVS Health stock opened at $59.02 on Friday. The firm has a market cap of $74.09 billion, a price-to-earnings ratio of 10.37, a PEG ratio of 0.81 and a beta of 0.53. The stock’s 50-day moving average is $58.18 and its 200 day moving average is $62.17. The company has a debt-to-equity ratio of 0.83, a current ratio of 0.86 and a quick ratio of 0.66. CVS Health Co. has a one year low of $52.77 and a one year high of $83.25.

CVS Health (NYSE:CVS) last announced its quarterly earnings data on Wednesday, August 7th. The pharmacy operator reported $1.83 EPS for the quarter, topping the consensus estimate of $1.73 by $0.10. CVS Health had a net margin of 1.98% and a return on equity of 12.72%. The company had revenue of $91.23 billion during the quarter, compared to the consensus estimate of $91.41 billion. During the same quarter last year, the firm posted $2.21 EPS. The company’s quarterly revenue was up 2.6% on a year-over-year basis. Equities research analysts anticipate that CVS Health Co. will post 6.51 EPS for the current year.

CVS Health Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Friday, November 1st. Stockholders of record on Monday, October 21st will be given a dividend of $0.665 per share. The ex-dividend date of this dividend is Monday, October 21st. This represents a $2.66 dividend on an annualized basis and a dividend yield of 4.51%. CVS Health’s dividend payout ratio (DPR) is presently 46.75%.

About CVS Health

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.